Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

Williet, Nicolas, Sandborn, William J., Peyrin–Biroulet, Laurent·2014·Clinical Gastroenterology and Hepatology

DOI 10.1016/j.cgh.2014.02.016

Cited by (260)

Items 101–200 of 260

Gastrointestinal Symptoms Predictors of Health‐Related Quality of Life in Patients With Inflammatory Bowel Disease
James W. Varni, Robert Jay Shulman, Mariella Marie Self, Shehzad Ahmed Saeed, Ashish Patel, Samuel Nurko, Deborah A. Neigut, Miguel Saps, James P. Franciosi, Jolanda M. Denham et al. · 2016 · Journal of Pediatric Gastroenterology and Nutrition
The Stressometer: A Simple, Valid, and Responsive Measure of Psychological Stress in Inflammatory Bowel Disease Patients
Keegan, Denise, Byrne, Kathryn, Cullen, Garret, Doherty, Glen A., Dooley, Barbara, Mulcahy, Hugh E. · 2015 · Journal of Crohn s and Colitis
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
María José Casanova, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, Patricia Suárez-Álvarez, Rocío Ferreiro‐Iglesias, María del Mar Martín-Rodríguez, Ruth de Francisco, Pilar Varela Trastoy et al. · 2024 · Digestive and Liver Disease
Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease
Guillaume Bonnaud, Audrey Haennig, Romain Altwegg, Bénédicte Caron, Lucile Boivineau, Camille Zallot, Cyrielle Gilleta de Saint-Joseph, Jacques Moreau, Florent Gonzalez, Didier Reynaud et al. · 2021 · Scandinavian Journal of Gastroenterology
Incidence, Disease Burden, and Clinical Presentation of Patients Newly Diagnosed With Inflammatory Bowel Disease in a Population-Based Inception Cohort
Mohamed Attauabi, Gorm Roager Madsen, Flemming Bendtsen, Jakob Benedict Seidelin, Johan M. Burisch · 2024 · Journal of Crohn s and Colitis
Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic
Jason Reinglas, Sophie Restellini, Lóránt Gönczi, Zsuzsanna Kürti, Christine Verdon, Sofia Nene, Rita Kohen, Waqqas Afif, Talat Bessissow, Gary Wild et al. · 2018 · Digestive and Liver Disease
Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial
Purificación Bernabeu, Carlos J. van-der Hofstadt Román, Jesús Rodríguez Marín, Ana Gutiérrez, Miguel R. Alonso, Pedro Zapater, Rodrigo Jover, Laura Sempere · 2021 · International Journal of Environmental Research and Public Health
Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn’s Disease
Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, Lars Kristian Munck, Lisbet Ambrosius Christensen, Gitte Pedersen, Jens Kjeldsen, Mark Andrew Ainsworth · 2015 · Journal of Crohn s and Colitis
The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
Satimai Aniwan, David H. Bruining, Sang Hyoung Park, Badr Al‐Bawardy, Sunanda V. Kane, Nayantara Coelho Prabhu, John B. Kisiel, Laura E. Raffals, Konstantinos Antonios Papadakis, Darrell S. Pardi et al. · 2019 · Journal of Clinical Medicine
Large Language Models Outperform Traditional Natural Language Processing Methods in Extracting Patient-Reported Outcomes in Inflammatory Bowel Disease
Perseus V. Patel, Conner Davis, Amariel Ralbovsky, Daniel Tinoco, Christopher Y. K. Williams, Shadera Slatter, Behzad Naderalvojoud, Michael J. Rosen, Tina Hernandez‐Boussard, Vivek Ashok Rudrapatna · 2024 · Gastro Hep Advances
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
Jamie M. Horrigan, Edouard J. Louis, Antonino Spinelli, Simon P.L. Travis, Bjørn Allan Moum, Jessica K. Salwen‐Deremer, Jonas Halfvarson, Remo Panaccione, Marla Cindy Dubinsky, Pia Munkholm et al. · 2023 · Crohn s & Colitis 360
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN’S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN’S DISEASE AND COLITIS (GEDIIB)
Marcello Rabello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo, Adriana Ribas Andrade, Natália Sousa Freitas Queiroz, Júlio Maria Fonseca Chebli, Liliana Andrade Chebli, Marjorie Costa ARGOLLO, Lígia Yukie Sassaki, Rogério Serafim Parra et al. · 2023 · Arquivos de Gastroenterologia
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process
Liselotte Fierens, Nicholas Carney, Gottfried Novacek, C. Janneke van der Woude, Britta Siegmund, Francesc Casellas, Natalia Borruel, Anouk Sjoukje Huberts, Elena Sonnenberg, Nathalie Gerold et al. · 2023 · Journal of Crohn s and Colitis
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease
Subrata K. Ghosh, Brian G. Feagan, Rogério Serafim Parra, Susana Lopes, Adam F. Steinlauf, Yoichi Kakuta, Namita Joshi, Wan‐Ju Lee, Ana Paula Lacerda, Qian Zhou et al. · 2024 · Journal of Crohn s and Colitis
Impact of various central endoscopy reading models on treatment outcome in Crohn’s disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial
Walter Reinisch, Daniel S. Mishkin, Young S. Oh, Stefan Schreiber, Fez Hussain, Rhian Jacob, Azra Hassanali, Marco Daperno · 2020 · Gastrointestinal Endoscopy
Examination of the relationship between disease activity and patient‐reported outcome measures in an inflammatory bowel disease cohort
Belinda D. Jackson, Danny Con, Alexandra Gorelik, Danny Liew, Simon Robert Knowles, Peter P. De Cruz · 2018 · Internal Medicine Journal
Patient-Reported Outcomes in Colorectal Surgery
Marianna Maspero, Tracy Lynn Hull · 2023 · Clinics in Colon and Rectal Surgery
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?
Federica Bellone, Carmela Morace, Giulia Impalà, Anna Viola, Alberto Lo Gullo, Maria Cinquegrani, Walter Fries, Alberto Sardella, Mariangela Scolaro, Giorgio Basile et al. · 2023 · Journal of Personalized Medicine
Phase III Placebo-Controlled, Randomized Clinical Trial With Synthetic Crohn's Disease Patients to Evaluate Treatment Response
Vida Abedi, Pinyi Lu, Raquel Hontecillas, Meghna Verma, Gavin Vess, Casandra Washington Philipson, Adria Carbo, Andrew J. Leber, N.T. Juni, Stefan Hoops et al. · 2016 · Elsevier eBooks
A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease
Edward L. Barnes, Michael D. Kappelman, Millie D. Long, Donna M. Evon, Christopher F. Martin, Robert S. Sandler · 2019 · The American Journal of Gastroenterology
The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage
Natasha Seaton, Vari Wileman, Christine S Norton, Joanna L. Hudson, Valeria Mondelli, Rona E Moss-Morris · 2025 · BMC Gastroenterology
Assessment of Inflammatory Bowel Disease Patient's Needs and Problems from a Nursing Perspective
Hanna Burkhalter, Prisca Stucki-Thür, Birgit David, Sven Lorenz, Beatrice Biotti, Gerhard Rogler, Valerie E. H. Pittet, and the Swiss IBD Cohort Study Group · 2015 · Digestion
The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials
Laurent Peyrin‐Biroulet, Corinne Gower‐Rousseau · 2016 · Journal of Crohn s and Colitis
Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective
Patrick B. Allen, Stefanos Bonovas, Silvio Danese, Laurent Peyrin‐Biroulet · 2019 · Expert Opinion on Biological Therapy
Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease
Sang Hyoung Park, Satimai Aniwan, Edward V. Loftus · 2017 · Current Opinion in Pharmacology
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease
Emily C L Wong, Elisa Buffone, So Jeong Lee, Parambir Singh Dulai, John Kenneth Marshall, Walter Reinisch, Neeraj Narula · 2020 · Journal of Crohn s and Colitis
Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients
Chiara M. Conti, Ilenia Rosa, Luigia Zito, Laurino Grossi, Konstantinos Efthymakis, Matteo Neri, Piero Porcelli · 2021 · Frontiers in Psychiatry
Inflammatory Bowel Disease and Pain Interference: A Conceptual Model for the Role of Insomnia, Fatigue, and Pain Catastrophizing
Carrie Falling, Corey Allan Siegel, Jessica K. Salwen‐Deremer · 2022 · Crohn s & Colitis 360
PROMises Made, PROMises To Be Kept: Patient-Reported Outcome Measures in Inflammatory Bowel Diseases
Siddharth Singh · 2018 · Clinical Gastroenterology and Hepatology
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN’S DISEASE AND COLITIS (GEDIIB)
Faculdade de Medicina de Botucatu, Júlio Pinheiro Baima, Marcello Rabello Imbrizi, Adriana Ribas Andrade, Liliana Andrade Chebli, Marjorie Costa ARGOLLO, Natália Sousa Freitas Queiroz, Matheus Freitas Cardoso de Azevedo, Andréa Vieira, Irmandade Santa Casa de Misericórdia de São Paulo et al. · 2023 · Arquivos de Gastroenterologia
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
Silvio Danese, Ailsa L Hart, Axel U Dignass, Edouard J. Louis, Geert D’Haens, Iris Dotan, Gerhard Rogler, Laurence D’Agay, Claudio Iannacone, Laurent Peyrin‐Biroulet · 2016 · BMJ Open Gastroenterology
Health-Related Quality of Life of Patients Treated with Biological Agents and New Small-Molecule Drugs for Moderate to Severe Crohn’s Disease: A Systematic Review
Hasan Aladraj, Mohamed Abdulla, Salman Yousuf Guraya, Shaista Salman Guraya · 2022 · Journal of Clinical Medicine
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey
Esther Chamorro‐de‐Vega, Rosa María Romero-Jiménez, Vicente Escudero‐Vilaplana, Arantza Ais‐Larisgoitia, María Elena Lobato Matilla, Carlos Manuel González, Luis A. Menchen, Ofelia Baniandrés, Lucía Ibares-Frias, Carmen Lobo-Rodríguez et al. · 2022 · Journal of Medical Internet Research
Evolving roles of cross-sectional imaging in Crohn's disease
Andrea Magarotto, Stefania Orlando, Marina Coletta, Dario Conte, Mirella Fraquelli, Flavio Caprioli · 2016 · Digestive and Liver Disease
Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals
Valerie E. H. Pittet, Michel H. Maillard, Thomas Simonson, Nicolas Fournier, Gerhard Rogler, Pierre Michetti, Claudia Anderegg, Peter Bauerfeind, Christoph Beglinger, Stefan Begré et al. · 2018 · Clinical Gastroenterology and Hepatology
Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease
Anthony R. Otley · 2012 · Springer eBooks
Biopsychosocial correlates of presence and intensity of pain in adolescents with inflammatory bowel disease
Murphy, Lexa K., Rights, Jason D., Ricciuto, Amanda, Church, Peter C., Ahola Kohut, Sara · 2020 · Frontiers in Pediatrics
Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
Nagesh Kamat, Sudheer Kumar Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev et al. · 2022 · Intestinal Research
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial
Julián Panés, Séverine Vermeire, Geert D’Haens, Silvio Danese, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà et al. · 2023 · United European Gastroenterology Journal
Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
Jon Ragnar Florholmen, Kay-Martin Johnsen, R Meyer, Trine Olsen, Øystein K. Moe, Petter Tandberg, Mona Dixon Gundersen, Jan‐Magnus Kvamme, Knut Johnsen, Terje Løitegård et al. · 2020 · BMC Gastroenterology
Week 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial
Masakazu Nagahori, Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai∥, Toshiyuki Matsui, Yasuo Suzuki, Philippe Pinton, Lyann Ursos, Shigeru Sakamoto et al. · 2021 · Digestion
Evolution of Clinical Trials in Inflammatory Bowel Diseases
Siddharth Singh · 2018 · Current Gastroenterology Reports
Impact of surgery on quality of life in Crohn’s disease: short- and mid-term follow-up
Stefano D’Ugo, Francesca Romano, Simone Sibio, Giulia Bagaglini, Bruno Sensi, Livia Biancone, Giovanni Monteleone, Giuseppe Sigismondo Sica · 2020 · Updates in Surgery
The Cost of Inflammatory Bowel Disease Management Matches with Clinical Course: A Single Outpatient Centre Analysis
Mariabeatrice Principi, Nunzia Labarile, Francesco Paolo Bianchi, Antonella Contaldo, Silvio Tafuri, Enzo Ierardi, Alfredo Di Leo · 2020 · International Journal of Environmental Research and Public Health
Development of a conceptual model evaluating the humanistic and economic burden of Crohn’s disease: implications for patient-reported outcomes measurement and economic evaluation
Adam Gater, Helen Kitchen, Louise Heron, Catherine Pollard, Jonas Håkan‐Bloch, Lise Højbjerre, Brian Bekker Hansen, Martin Strandberg-Larsen · 2015 · Expert Review of Pharmacoeconomics & Outcomes Research
Resolution of dominant patient‐reported outcome at end of induction predicts clinical and endoscopic remission in Crohn’s disease
Emily C L Wong, Parambir Singh Dulai, John Kenneth Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula · 2022 · Alimentary Pharmacology & Therapeutics
Topical Therapy in Ulcerative Colitis: Always a Bridesmaid but Never a Bride?
Subrata K. Ghosh, Marco Daperno · 2015 · Gastroenterology
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease
Julián Panés, Edouard J. Louis, Peter J. Bossuyt, Namita Joshi, Wan‐Ju Lee, Ana Paula Lacerda, Kristina R. Kligys, Si Xuan, Nidhi Shukla, Edward V. Loftus · 2024 · Inflammatory Bowel Diseases
Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone?
Amy K Grant, Trudy Lerer, Anne Marie Griffiths, JS Hyams, Anthony R. Otley · 2021 · World Journal of Gastroenterology
Established Management Paradigms in IBD: Treatment Targets and Therapeutic Tools
Miguel D. Regueiro, Julia B. Greer, Stephen B. Hanauer · 2016 · The American Journal of Gastroenterology Supplements
Estimation of quality of life in Cypriot patients with inflammatory bowel disease
Maria Tsoukka, Eleni Jelastopulu, Giagkos M. Lavranos, George Charalambous · 2017 · World Journal of Gastroenterology
Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative
Nisha B. Shah, Jacob A. Jolly, Sara Horst, Megan E. Peter, Heather M. Limper, Autumn D. Zuckerman · 2019 · American Journal of Health-System Pharmacy
Black/African American Patients with Pediatric Crohn's Disease Report Less Anxiety and Fatigue than White Patients
Arielle Grossman, Elizabeth A. Mauer, Linda M. Gerber, Millie D. Long, Michael D. Kappelman, Neera Gupta · 2020 · The Journal of Pediatrics
Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn’s Disease
Eun Soo Kim, Sung Kook Kim, Byung Ik Jang, Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Sang Gyu Kwak · 2018 · Digestive Diseases and Sciences
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease
Laurent Peyrin‐Biroulet, Edouard J. Louis, Edward V. Loftus, Ana Paula Lacerda, Qian Zhou, Yuri Sánchez González, Subrata K. Ghosh · 2021 · Advances in Therapy
Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India
Arshdeep Singh, Arshia Bhardwaj, Ashish Tripathi, Mukesh Kumar Ranjan, Dharmatma Singh, Ashi Sachdeva, Mahima Marwah, Kriti Sood Sadana, Namita Bansal, Ramit Mahajan et al. · 2024 · Digestive Diseases and Sciences
Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study
Thierry Paupard, Florent Gonzalez, Bénédicte Caron, Laurent Siproudhis, Laurent Peyrin‐Biroulet · 2022 · European Journal of Gastroenterology & Hepatology
BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN’S DISEASE AND COLITIS (GEDIIB)
Elizete Aparecida Lomazi, Jane Oba, Maraci Rodrigues, Michela Cynthia da Rocha Marmo, Natascha Silva Sandy, Vera Lúcia Sdepanian, Marcello Rabello Imbrizi, Júlio Pinheiro Baima, Daniéla Oliveira Magro, Idblan Carvalho de Albuquerque et al. · 2023 · Arquivos de Gastroenterologia
The informational and decisional preferences of patients undergoing surgery for Crohn’s anal fistula: a qualitative study
Matthew J. Lee, Jack H. Marshall, Georgina Louise Jones, Alan Lobo, Steven Ross Brown · 2019 · Colorectal Disease
Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward
Amanda Ricciuto, Ingrid Rauter, Dermot P.B. McGovern, Robert M. Mader, Walter Reinisch · 2022 · Gastroenterology
HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH REDUCTION IN SCHOOL AND WORK PRODUCTIVITY RATHER THAN PHYSICAL IMPAIRMENT: A MULTIDISCIPLINARY STUDY
Jane Oba, Carlos Walter Sobrado, Adérson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, Natália Sousa Freitas Queiroz, Cláudio Arnaldo Len, Ricardo Katsuya Toma, Mariana Deboni, M Ozaki et al. · 2021 · Arquivos de Gastroenterologia
Patient-reported outcome measures and surgery for Crohn’s disease: systematic review
Whei J Kim, Mohamad Iskandarani, Carlo Alberto Manzo, Gianluca Pellino, Marc Martí, Paris P Tekkis, Valerio Celentano, Christos Kontovounisios · 2023 · BJS Open
Expert opinions on informational and supportive needs and sources of obtaining information in patients with inflammatory bowel disease: a Delphi consensus study
Narges Norouzkhani, Ali Bahari, Javad Shokri‐Shirvani, Mahbobeh Faramarzi, Saeid Eslami, Hamed Tabesh · 2023 · Frontiers in Psychology
Evaluation of the efficacy of octreotide LAR in the treatment of Crohn’s disease associated refractory diarrhea
Laura Martelli, Arnaud Colard, Fernand Fontaine, Jacques deFlandre, Boris Bastens, Edouard J. Louis · 2017 · Scandinavian Journal of Gastroenterology
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease
Sofie Coenen, Ellen Weyts, Patricia Geens, Séverine Vermeire, Marc Ferrante, Kris Vanhaecht, Gert Van Assche · 2019 · Scandinavian Journal of Gastroenterology
Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
J. Bajaj, Darren M. Brenner, Qiang Cai, B. Cash, Michael D. Crowell, John K. DiBaise, J. Gallegos-Orozco, Timothy B. Gardner, C. Gyawali, Christina Ha et al. · 2020 · American Journal of Gastroenterology
Validation of the PROMIS Global Physical and Mental Health Scale for Gastrointestinal Disorders: A Large‐Scale Cross‐Sectional Survey
Pragalathan Apputhurai, Olafur Steinn Palsson, Shrikant I. Bangdiwala, Ami David Sperber, Antonina A Mikocka‐Walus, Simon Robert Knowles · 2025 · Neurogastroenterology & Motility
Burden of Inflammatory Bowel Disease on Patient Mood, Fatigue, Work, and Health-Related Quality of Life in Thailand: A Case-Control Study
Kasenee Tiankanon, Julajak Limsrivilai, Napapat Poocharoenwanich, Phutthaphorn Phaophu, Nichcha Subdee, Natanong Kongtub, Satimai Aniwan · 2021 · Crohn s & Colitis 360
Characterizing the Parental Perspective of Food-Related Quality of Life in Families After Pediatric Inflammatory Bowel Disease Diagnosis
Kelly R. Fisher, Laura D. Byham-Gray, Pamela Rothpletz‐Puglia · 2021 · Gastroenterology Nursing
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation
Darragh Storan, Edel McDermott, Jenny Moloney, Lisa Keenan, Róisín Stack, Juliette Sheridan, Glen A. Doherty, Garret J. Cullen, Louise McHugh, Hugh E. Mulcahy · 2023 · Frontline Gastroenterology
Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children
Dana-Teodora Anton-Păduraru, Alice Nicoleta Azoicai, Felicia Trofin, Alina Mariela Murgu, Dana Elena Mîndru, Ana Simona Bocec, Codruța-Olimpiada Halițchi-Iliescu, Gabriela Rusu Zota, Diana Păduraru, Eduard Vasile Năstase · 2024 · Diagnostics
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants
Virginia Solitano, Heather Prins, Meagan Archer, Leonardo Guizzetti, Vipul Jairath · 2024 · Crohn s & Colitis 360
Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease
Davide Scalvini, Chiara Scarcella, Giulia Mantica, Erica Bartolotta, Stiliano Maimaris, Erica Fazzino, Federico Biagi, Annalisa Schiepatti · 2025 · Frontiers in Nutrition
How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems
Anna M. Buchner, Gary R. Lichtenstein · 2016 · Inflammatory Bowel Diseases
Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study
Catherine Le Berre, Arnaud Bourreille, Mathurin Flamant, Guillaume Bouguen, Laurent Siproudhis, Marie Dewitte, Nina Dib, Élodie Cesbron-Métivier, Thomas Goronflot, Matthieu Hanf et al. · 2020 · BMC Gastroenterology
Flare-IBD: development and validation of a questionnaire based on patients’ messages on an internet forum for early detection of flare in inflammatory bowel disease: study protocol
Laetitia Ricci, Jonathan Epstein, Anne Buisson, Corinne Devos, Yannick Toussaint, Laurent Peyrin‐Biroulet, Françis Guillemin · 2020 · BMJ Open
Evolving Therapeutic Strategies in the Inflammatory Bowel Disease
Soo-Young Na, Won Moon · 2018 · Korean Journal of Gastroenterology
Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis
Eric D. Shah, Corey Allan Siegel, Kelly Chong, GIL Y. MELMED · 2016 · Inflammatory Bowel Diseases
The Concept of Mucosal Healing in Ulcerative Colitis: Time and Reasons for a Reappraisal
Antonio López–Sanromán · 2015 · Journal of Crohn s and Colitis
Defining success in treating patients with inflammatory bowel disease
Klaus Theede, Johan M. Burisch · 2017 · Expert Review of Clinical Immunology
Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey
George Gourzoulidis, V.R. Vakouftsi, George Mavridoglou, Marina Psarra, Charalampos Tzanetakos · 2025 · Medical Sciences
Psychological distress predicts disease activity in inflammatory bowel disease: Results from the mind-body IBD longitudinal study
Natasha Seaton, Joanna L. Hudson, Valeria Mondelli, Leah Raymond, Pooja Schmill, Ailsa L Hart, Rona E Moss-Morris · 2025 · Brain Behavior & Immunity - Health
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis
Tanmay Sharma, Christopher Ma, Rocío Sedaño, Jurij Hanžel, Cassandra L. McDonald, Malcolm Hogan, Gursimran Singh Kochhar, Neeraj Narula, Laurent Peyrin‐Biroulet, Silvio Danese et al. · 2022 · Journal of Crohn s and Colitis
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review
Sophie Vieujean, Bruce E. Sands, Remo Panaccione, David T. Rubin, Vipul Jairath, Silvio Danese, Laurent Peyrin‐Biroulet, Stefan Schreiber, Séverine Vermeire, Geert D’Haens et al. · 2025 · Journal of Crohn s and Colitis
Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease
Kendra Kamp, Manfred Stommel · 2020 · Gastroenterology Nursing
Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS)
Daniel C. Baumgart, Andreas Stallmach, Philip Grunert, Stefan Schubert, Stefanie M. Howaldt, Ulrike von Arnim, Thomas Ochsenkühn, Jürgen M. Stein, Andreas Lügering, Daniel N. Schmidt et al. · 2024 · Scientific Reports
Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients With Inflammatory Bowel Disease
Sang Hyoung Park, Badr Al‐Bawardy, Satimai Aniwan, Sunanda V. Kane, Nayantara Coelho–Prabhu, Konstantinos Antonios Papadakis, John B. Kisiel, David H. Bruining, William A. Faubion, Laura E. Raffals et al. · 2019 · Crohn s & Colitis 360
New models of care in IBD in changing times
Peter P. De Cruz · 2016 · Journal of Gastroenterology and Hepatology
Editorial: Using Patient-Reported Outcome Measures in Gastroenterology: PROMISed Land or Road to Nowhere?
David J. Gracie, Alexander Charles Ford · 2016 · The American Journal of Gastroenterology
Development of a validated Chinese version of the inflammatory bowel disease disability index
Jing Jing Zhang, Dan Na Lou, Han Ma, Chao Yu, Li Hua Chen, You Ming Li · 2019 · Journal of Digestive Diseases
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn’s Disease
Neeraj Narula, Emily C L Wong, Achuthan Aruljothy, Parambir Singh Dulai, Jean‐Frédéric Colombel, John Kenneth Marshall, Marc Ferrante, Walter Reinisch · 2022 · Journal of Clinical Gastroenterology
New approach methodologies in Crohn’s disease link molecular disease subtypes to clinical outcomes
Harrison M. Penrose, Saptarshi Sinha, Courtney Tindle, Kameron M. Zablan, Helen N. Le, Jennifer Neill, Pradipta Ghosh, Brigid Sweeney Boland · 2026 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review
Zakary Ismail Warsop, Carlo Alberto Manzo, Natalie Yu, Bilal Yusuf, Christos Kontovounisios, Valerio Celentano · 2023 · Journal of Crohn s and Colitis
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study
Scott David Lee, Séverine Vermeire, Ryan C. Ungaro, Aisha Vadhariya, Frédérick Durand, Nathan J. Morris, Guanglei Yu, Deborah A. Fisher, Kristina Traxler, Millie D. Long · 2025 · The American Journal of Gastroenterology
Normative data for the Brief Symptom Inventory for patients with Crohn's disease
Shirley Regev, Shmuel Odes, Vered Slonim‐Nevo, Ganit Goren, Michael D Friger, Dan Greenberg, Hillel Vardi, Doron Schwartz, Ruslan Sergienko, Orly Sarid · 2021 · Psychology and Health
Defining Severity in Inflammatory Bowel Disease.
Laurent Peyrin‐Biroulet · 2015 · PubMed Central
Disparity in Crohn’s disease activity between home and clinics is associated with unscheduled hospital visits due to disease flares
Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Eun Young Kim, Hyun Seok Lee, Seong Woo Jeon, Sang Gyu Kwak · 2018 · The Korean Journal of Internal Medicine
Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease
Amy K Grant, Anthony R. Otley · 2017 · Springer eBooks
Deconstructing disability in inflammatory bowel disease.
J. Sellin · 2014 · Clinical Gastroenterology and Hepatology
Fatigue and mood disorders are highly prevalent in patients with inflammatory bowel disease: a single‐centre, cross‐sectional study using patient‐reported outcomes
Andrew Chen, Darren Wong · 2026 · Internal Medicine Journal